We detected des-gamma-carboxy prothrombin, an abnormal prothrombin, in the serum of 69 of 76 patients (91 per cent) with biopsy-confirmed hepatocellular carcinoma (the mean level of the abnormal prothrombin was 900 ng per milliliter). In contrast, levels of the abnormal prothrombin were low in patients with chronic active hepatitis (mean, 10 ng per milliliter) or metastatic carcinoma involving the liver (mean, 42 ng per milliliter), and undetectable in normal subjects. In five patients treated with vitamin K there was no reduction in abnormal prothrombin, indicating that its presence was not due to vitamin K deficiency. Surgical resection of tumors in two patients and chemotherapy in one patient markedly reduced abnormal-prothrombin concentrations, which later increased with recurrence of disease. Serum alpha-fetoprotein levels correlated poorly with abnormal-prothrombin levels. Together, the assay for abnormal prothrombin and the alpha-fetoprotein assay identified 64 of 76 patients with hepatoma (84 per cent). Abnormal prothrombin may be useful in the laboratory diagnosis of primary hepatocellular carcinoma.
This article has been cited by other articles:
Suzuki, M., Shiraha, H., Fujikawa, T., Takaoka, N., Ueda, N., Nakanishi, Y., Koike, K., Takaki, A., Shiratori, Y.
(2005). Des-{gamma}-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma. J. Biol. Chem.
280: 6409-6415
[Abstract][Full Text]
Gotoh, M., Nakatani, T., Masuda, T., Mizuguchi, Y., Sakamoto, M., Tsuchiya, R., Kato, H., Furuta, K.
(2003). Prediction of Invasive Activities in Hepatocellular Carcinomas with Special Reference to {alpha}-Fetoprotein and Des-{gamma}-carboxyprothrombin. Jpn J Clin Oncol
33: 522-526
[Abstract][Full Text]
Ryder, S D
(2003). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut
52: iii1-8
[Full Text]
Pereira, S P, Shearer, M J, Williams, R, Mieli-Vergani, G
(2003). Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch. Dis. Child. Fetal Neonatal Ed.
88: F113-F118
[Abstract][Full Text]
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B.
(2000). Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests. Clin. Chem.
46: 2027-2049
[Abstract][Full Text]
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B.
(2000). Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clin. Chem.
46: 2050-2068
[Abstract][Full Text]
Takata, M., Yamanaka, N., Tanaka, T., Yamanaka, J., Maeda, S., Okamoto, E., Yasojima, H., Uematsu, K., Watanabe, H., Uragari, Y.
(2000). What Patients Can Survive Disease Free After Complete Resection for Hepatocellular Carcinoma?: A Multivariate Analysis. Jpn J Clin Oncol
30: 75-81
[Abstract][Full Text]
Nishikawa, Y., Carr, B. I., Wang, M., Kar, S., Finn, F., Dowd, P., Zheng, Z. B., Kerns, J., Naganathan, S.
(1995). Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs. J. Biol. Chem.
270: 28304-28310
[Abstract][Full Text]
Previous
